glp-1 pharma companies 2025’s Breakthrough Obesity Treatments: Top & Innovations GLP-1 Receptor Agonist Companies and
Description
May 16, 2024

2012 Jan;38(1):104-10
Comment on: the effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy [published online ahead of print June 20, 2025]

A once-daily Wegovy pill was approved in late December 2025
